I
nhalation injury (INHI) is a comorbid factor that increases the risk of mortality in burn victims (1) (2) (3) . The combination of INHI and burn is associated with complex pathophysiological alterations including increased pulmonary microvascular permeability and prolonged cardiac depression in ovine models (4, 5) . In a Canadian study, Tredget et al (6) reported that INHI increases burn mortality and prolongs hospital stay independent of age and burn size. In spite of the clinical significance of INHI, there has been a lack of academic progress in the clinical management in this field.
Palmieri (7) concluded from the 2007 Inhalation Injury Consensus Conference that questions regarding INHI diagnosis and grading have remained unanswered even though they were initially identified more than two decades previously. Although fibreoptic bronchoscopy is the widely accepted standard to diagnose INHI, other modalities, such as patient history and physical examination, carboxyhemoglobin levels, Xenon-133 scans and pulmonary function tests are used in various nonstandardized combinations (8) . There is also insufficient evidence to establish long-term outcomes and treatment protocols in INHI. The use of heparin nebulization, mode of ventilation, timing of intubation and fluid resuscitation requirements are mostly driven by local preferences in individual burn centres.
The controversies in the areas of INHI highlight the need for standardized protocols in both diagnosing and treating INHIs. However, the first step is to evaluate current practices. The challenge is that most Canadian burn centres do not have a sufficient volume of burn patients to support substantial scientific studies. Therefore, the issue should be approached on a national level. There are no studies that have compiled current practices in North America. The objective of the present study was to summarize current Canadian practice patterns in the diagnosis of and interventions for INHI.
Methods
The authors designed a 10-question survey (Appendix A) regarding the diagnosis and interventions of INHI. After receiving approval from the University of British Columbia Institutional Review Board (Vancouver, British Columbia), the authors sent the survey to the medical directors of all 16 burn centres across Canada. Following verification of contact information of the burn centres by telephone, an invitation letter was sent electronically; the surveys were then sent in July 2009 by e-mail. A repeat batch of surveys were e-mailed and mailed at two weeks to remind burn centre directors of the option to participate. If no response was received at this time, the authors assumed decline of participation. Returned surveys represented consent to participate in the study. Completed surveys were collected by the principle investigator via fax or e-mail. Individual respondent identifiers were then removed after the data were collected. All results were recorded as provided and compiled using a spreadsheet (Excel, Microsoft Corporation, USA). 
ResuLts demographics
Overall, eight of 16 (50%) Canadian burn centres responded to the survey. The demographics of the respondents are presented in Table 1 . The respondents represented the largest burn centres in Canada. The mean number of patients in the respondent burn centres was 106 patients per year. One-half of the respondents were large centres with >125 patients per year. All but one burn centre had a formal burn protocol. All centres had a plastic surgeon involved as the director. bronchoscopic diagnosis of inhi Fibreoptic bronchoscopy was required for the diagnosis of INHI in only four (50%) burn centres. The intensive care unit was involved in performing fibreoptic bronchoscopy in seven centres (87.5%), and the departments of otolaryngology and respirology were involved in one centre (12.5%), respectively. A total of three centres (37.5%) involved the department of plastic surgery in performing the procedure; however, only one (12.5%) relied solely on plastic surgery. Staff physicians performed bronchoscopy in all eight burn centres (100%) whereas residents were involved in three (37.5%) and Fellows were involved in two (12.5%).
Clinical diagnosis of inhi
Intubation for INHI was most oftern based on physical examination results (87.5%) and clinical history (75%) (Figure 1 ). The top three physical examination features believed to be most consistent with INHI were dyspnea (87.5%), hoarseness (87.5%) and carbonaceous sputum (75%) (Figure 2) .
treatment of inhi
The most common treatments for INHI were intubation (87.5%), ventilator support (87.5%) and chest physiotherapy (75%); no centre routinely used nebulized heparin to treat INHI (Figure 3) . A total of five centres (62.5%) routinely changed the fluid resuscitation protocol when INHI was diagnosed (Figure 4 ).
Antibiotic prophylaxis
Only seven of eight centres (87.5%) responded to the question of whether antibiotic prophylaxis was used for the diagnosis of INHI. Of the seven respondent centres, two (28.5%) routinely used antibiotic prophylaxis in patients with comorbidities; one centre (14.3%) responded 'not usually' and the rest (57.1%) have never considered using antibiotic prophylaxis in the management of INHI ( Figure 5 ).
disCussion
The proper early diagnosis of INHI is of great clinical importance because INHI significantly increases morbidity and mortality in burn patients. Many studies support the value of fibreoptic bronchoscopy in diagnosing INHI. In a prospective study involving 130 patients (9), fibreoptic bronchoscopy was found to be more reliable than circumstance of the injury, clinical findings and complementary tests in early diagnoses of INHI, with 94% specificity and 79% sensitivity compared with histological findings. In fact, sensitivity may improve when fibreoptic bronchoscopy is repeated in 24 h to 48 h in patients with hypovolemic shock (8, 10) . Using a self-devised bronchoscopic grading system, several authors concluded that fibreoptic bronchoscopy was a useful tool in predicting acute lung injuries and overall survival (9, 11, 12) . On the other hand, Bingham et al (13) concluded that their devised bronchoscopic index was not a good predictor of the level of respiratory support or the duration of intubation in burn patients. Although there are no evidence-based protocols guiding the diagnosis and grading of INHI, it was startling to observe that bronchoscopy -the widely accepted standard of INHI diagnosis that was first used 35 years ago (10) -was only used in 50% of the surveyed Canadian burn centres.
Despite being the specialists in burn surgery and management in Canada, plastic surgeons are only reported to perform fibreoptic bronchoscopy alone in 12.5% of the surveyed burn centres. In addition, it is significant that only 37.5% of the burn centres involve plastic surgery residents in performing the procedure. The increased involvement of plastic surgery and residents in Canadian burn care could explain why bronchoscopy is only used 50% of the time for diagnosis.
Our survey showed that physical examination findings and clinical history were the top criteria guiding the diagnosis of INHI in Canada. History of injury in a closed space, facial burns, large burn sizes or advanced age should increase the clinician's suspicion in diagnosing INHI (1). Although these modalities cannot ensure diagnostic certainty, they are routinely used in Canada because of their noninvasive (14) reported that dyspnea, hoarseness and carbonaceous sputum were only present in 3%, 19% and 48% of the patients, respectively. Using only clinical signs to diagnose INHI is nonspecific and may explain the decrease in the trend of reported INHI-associated mortality due to the potential of overestimation from a misdiagnosis. Therefore, the use of a combination of findings appears to be more reliable in predicting INHI (15) . This, however, is still insufficient to validate the lack of fibreoptic bronchoscopy use in some Canadian burn centres. On the other hand, there is no consensus to proceed with which diagnostic modality or combination if the burn patient does not exhibit any suspicious physical findings. Some Canadian burn centres use arterial blood gas and chest x-ray to guide INHI diagnosis; however, due to low sensitivity, these were shown to be poor predictors of respiratory failure and death (16) . In the treatment of INHI, the majority of Canadian burn centres consistently focus on supportive therapy: intubation, ventilatory support and chest physiotherapy. None of the centres currently uses routine inhalational medications in treating INHI. Preliminary evidence supporting of the use of β 2 -agonists and tocopherol in INHI exists in animal models and small, single-centre, retrospective studies (17, 18) . However, with the lack of confirmation from prospective, multicentre clinical trials, their effectiveness and safety remain inconclusive. Another pharmacological option that has created controversy is the combination of nebulized heparin and N-acetylcystine. In a retrospective study, Desai et al (19) showed that this combination reduced mortality, atelectasis and reintubation rates in pediatric patients with INHI. However, a more recent retrospective study by Holt et al (20) showed no difference in pulmonary findings or mortality in adult patients treated with this combination. The evidence for nebulized heparin and N-acetylcystine is split, but it is interesting to note that this combination is not used at all in Canada.
Figure 1) Criteria guiding intubation for inhalation injuries in Canadian burn centres

Figure 2) Physical examination findings guiding intubation for inhalation injuries in Canadian burn centres
In the present study, 63% of all Canadian burn centres routinely changed the fluid resuscitation protocol when INHI was diagnosed because the evidence in support of an ideal protocol for patients with INHI is weak. Burn patients with INHI generally have increased fluid requirements (21, 22) ; however, they are also at risk of complications from fluid overload, such as compartment syndrome, acute respiratory distress syndrome, multiple organ failure and death (23) . Due to the complexity of pathophysiology in burn patients, especially those with concomitant INHI, it is challenging to elicit a predictable fluid response without an accurate fluid formula, appropriate monitoring parameters and measurable end points that are supported by substantial evidence.
The use of antibiotic prophylaxis upon diagnosis of INHI is a nonevidence-based practice observed in some Canadian burn centres.
There is currently no evidence to recommend the use of antibiotic prophylaxis in preventing infections in patients with INHI. In fact, in a prospective study, Levine et al (24) reported no differences in mortality, pulmonary and septic complications in patients with INHI treated with gentamicin versus placebo. It was unexpected to learn that only four of seven Canadian burn centres (57%) never used antibiotic prophylaxis in INHI.
There were several limitations to the present study. First, the low response rate (50%) raises concerns about the significance of the data. However, most of the data were represented by the largest burn centres in Canada and, therefore, the data obtained are important and valuable. Second, the answers to the survey were solely based on the burn directors' expert opinion in current burn management in their area; the perspectives from other integral members of the burn team were not represented. On a similar note, because most of the centre directors were plastic surgeons, their views regarding the management of INHI may be biased and different from other departments such as the intensive care unit or the emergency department.
Despite its shortcomings, the present study was the first in Canada to provide a nationwide perspective of the clinical management of INHI. The present study highlights the challenges in burn care with the paucity of evidence. The only other nationwide survey investigating the management of INHI was conducted by Prior et al (25) in the United Kingdom. The authors reported that 81% of the burn units in the United Kingdom require fibreoptic bronchoscopy to diagnose INHI, and no unit uses a purely clinical diagnosis; 76% of the units use nebulizing medications in treating INHI. From these findings, it is apparent that the management of INHI is inconsistent between the burn centres in the United Kingdom and Canada. With the lack of evidence-based guidelines, most practices regarding the management of INHI are governed by local custom of the individual burn centres. 
Figure 5) Proportion of Canadian burn centres that use antibiotic prophylaxis when inhalation injury is diagnosed
Evidence-based recommendations regarding the interventions for INHI relies on standardizing diagnosis (7) . Research efforts must be focused on the reproducible grading of INHI using bronchoscopy. Recognizing that clinical history and physical findings may be insufficient to define INHI, several authors have used objective grading scales to assess the severity of INHI via bronchoscopy (11, 26, 27) . Mosier et al (26) showed that higher abbreviated injury scores were associated with earlier onset of acute respiratory distress syndrome, longer intensive care unit stay and higher incidence of multiple organ dysfunction syndrome (11, 26) . One limitation of the present study was that it was a small retrospective cohort. Ikonomidis et al (27) used a different grading system that subcategorized bronchoscopic findings into upper airway and lower tracheobronchial tree to show that lower extension of injury is associated with prolonged mechanical ventilation. This was a single-centre study lacking external validation.
The current challenge is the absence of a uniform grading system that has been shown to reliably predict the clinical course of burn patients with INHI. We encourage joint efforts from the Canadian burn centres to prospectively evaluate a single bronchoscopic grading system in predicting clinical outcomes.
ConCLusion
Physical examination is the most common tool used in the diagnosis of INHI in Canada. Although fibreoptic bronchoscopy is the gold standard, it is only used 50% of the time for diagnosis. Interventions for INHI are fairly consistent across the nation, with the focus on supportive treatment without the use of nebulizing agents. Prospective, multicentre trials are needed to generate evidence-based consensus in the areas of diagnosis, grading and treatment of INHI in Canada.
